Dr. Uma Sharma has over 20 years’ experience in the pharmaceutical industry; particularly in late stage drug development. She has worked at Parke-Davis and Pfizer prior to her current position and has led large phase 3 programs, navigating clinical teams through two mergers, while strategically directing senior management through critical “Go” or “No Go” decisions at key stages in drug development.
As the Chief Scientific Officer at MMS Holdings Inc., Dr. Sharma has led several submission projects successfully including several advisory committee meetings for various sponsors. Dr. Sharma has participated in advisory boards for drug development as well as product defense strategies. She has been an invited speaker at several national and international meetings throughout her career.
At MMS Holdings Inc., she has been instrumental in setting the organization as one of the few ISO-9001 certified service-providing organizations and providing oversight for all clinical activities.
Dr. Sharma earned her doctorate in pharmacology from Wayne State University and the University of Michigan